Study on pharmacokinetics of isoniazid in dog after a high oral dose
Deng Lai-chun
Abstract
Deng Lai-chun
Abstract
Objective To study the pharmacokinetics of isoniazid in dog after a high oral dose.Methods Cross-over randomized design (two periods) was employed. one group was supplied with a high oral dose, while the other was supplied with common oral dose, and pharmacokinetic parameters were calculated and compared.Results The pharmacokinetics of isoniazid was fitted to a one-compartment model with first order absorption. Time to peak plasma coneentration were 2.23±0.78h and 0.96±0.32h.Elimination half life were 0.98±0.16h and 0.22±0.09h. The result of statistical analysis showed significant differeence(P0.05).Conclusions Isoniazid after a high oral dose in pharmacokinetics parameters were changed, time to peak plasma concentration and elimination half life were delayed.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the pharmacokinetics of isoniazid in dog after a high oral dose.Methods Cross-over randomized design (two periods) was employed. one group was supplied with a high oral dose, while the other was supplied with common oral dose, and pharmacokinetic parameters were calculated and compared.Results The pharmacokinetics of isoniazid was fitted to a one-compartment model with first order absorption. Time to peak plasma coneentration were 2.23±0.78h and 0.96±0.32h.Elimination half life were 0.98±0.16h and 0.22±0.09h. The result of statistical analysis showed significant differeence(P0.05).Conclusions Isoniazid after a high oral dose in pharmacokinetics parameters were changed, time to peak plasma concentration and elimination half life were delayed.
Key concepts: Pharmacokinetics, Isoniazid, Medicine, Oral dose, Pharmacology, Absorption (acoustics), Half-life, Oral route